Paul Faybusovich, D.O Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1900 Centracare Cir Ste 1325, Saint Cloud, MN 56303 Phone: 320-654-3650 Fax: 320-654-3681 |
News Archive
A new technique that could help improve diagnosis of vision disorders has been successfully tested at the University of Bradford, UK.
He sits at a kitchen table, nursing a cup of coffee, talking about what happened after Bain Capital closed down his steel plant in 2001. He lost his job; his family lost its health insurance. His wife felt lousy but didn't go to the doctor, to spare the family worry and expense. When she finally ended up in the hospital, the diagnosis was cancer. She had 22 days to live.
It's a fairly common genetic condition that can surface as a series of dark skin spots and result in a host of maladies from tumors to premature cardiovascular disease. Medical College of Georgia researchers hope their studies of how neurofibromatosis 1, or NF1, can dangerously thicken or thin blood vessel walls will one day help physicians better identify and treat these young patients at cardiovascular risk.
AirXpanders Inc., a medical device company focused on the design, manufacture, sale and distribution of the AeroForm Tissue Expander, is pleased to report that its pivotal XPAND trial has met its primary endpoint in patients who have undergone a mastectomy.
China Shenghuo Pharmaceutical Holdings, a China-based pharmaceutical company engaged in the research, development, manufacture, and marketing of Traditional Chinese Medicine, nutritional supplement and cosmetic products, today announced that "Lixuwang", the trademark of its best selling product, Xuesaitong Capsule, was awarded the Chinese Well-Known Trademark Honor by the State Administration for Industry and Commerce of China.
› Verified 3 days ago